Analysts have been eager to weigh in on the Healthcare sector with new ratings on Universal Health (UHS) and Progenity (PROG).
Universal Health (UHS)
Raymond James analyst John Ransom maintained a Hold rating on Universal Health yesterday. The company’s shares closed last Thursday at $105.45.
According to TipRanks.com, Ransom is a 5-star analyst with an average return of 8.7% and a 59.7% success rate. Ransom covers the Healthcare sector, focusing on stocks such as Acadia Healthcare, Community Health, and Encompass Health.
Universal Health has an analyst consensus of Moderate Sell, with a price target consensus of $115.00.
See today’s analyst top recommended stocks >>
Progenity (PROG)
In a report released today, Andrew Cooper from Raymond James maintained a Buy rating on Progenity. The company’s shares closed last Thursday at $5.96, close to its 52-week low of $5.92.
According to TipRanks.com, Cooper is a 3-star analyst with an average return of 12.5% and a 78.6% success rate. Cooper covers the Healthcare sector, focusing on stocks such as Orasure Technologies, Idexx Laboratories, and NeoGenomics.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Progenity with a $14.50 average price target, implying an 87.8% upside from current levels. In a report issued on October 23, BTIG also initiated coverage with a Buy rating on the stock with a $12.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.